GLP-1 Drug Disclaimer: Tirzepatide, Semaglutide, Liraglutide, Dulaglutide, Orforglipron are FDA-approved prescription medications for the treatment of type 2 diabetes and may also be prescribed for weight management when deemed appropriate by a licensed healthcare provider. Like all medications, they may cause side effects such as nausea, vomiting, constipation, diarrhea, or abdominal pain. Rare but serious risks include pancreatitis, gallbladder disease, thyroid tumors, or kidney problems. These medications are not suitable for everyone. Treatment decisions, including the choice of medication and dosage, will be made by your physician after a full medical evaluation.
All medications are dispensed through licensed U.S. pharmacies. Results vary, and weight loss is most effective when combined with medical supervision, lifestyle, and nutrition support. Brand name GLP-1 and GIP Agonists inlude Wegovy®, Ozempic®, Rybelsus®, Saxendra®, Zepbound®, Mounjaro®, Trulicity®, Foundayo®. Read more about GLP-1s at drugs.com




